Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Momed Qixuehe Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern medicinal products. The company is best known for its flagship product, Qixuehe Capsules, which are widely used for treating gynecological conditions and improving blood-qi circulation. Its business portfolio spans several therapeutic areas including women's health, cardiovascular diseases, and gastrointestinal disorders. Momed operates large-scale GMP-certified manufacturing facilities in Shaanxi Province and maintains an extensive distribution network across China. The enterprise emphasizes the modernization of traditional formulas through contemporary pharmacological validation and clinical research. By integrating traditional wisdom with modern standards, the company has established itself as a key player in the regional biopharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Momed Qixuehe Pharmaceutical.